Regenerative Medicine and Stem Cells Technologies

Japanese medical researchers just gained approval to treat patients with heart disease through a unique stem cell process.

American researchers reported on Friday in the journal Cell Stem Cell the first-in-human phase 1 clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement in three of four subjects, with no serious adverse effects.

The first human corneas have been 3D printed by scientists at Newcastle University.

School of Medicine researcher Bertha Chen, MD, has been awarded $5.98 million by the California Institute for Regenerative Medicine to investigate ways of using a person’s own stem cells to treat urinary incontinence.

Scott Gottlieb has kept himself busy during his tenure as head of the Food and Drug Administration.

According to data, of the total healthcare expenditure in the European Union, wound management makes up 2–4%. A single chronic wound can cost up to 10 thousand EUR to treat, and it is estimated that up to 1.5% of EU population has one or more of such wounds.

Researchers at Kanazawa University report in Cell Stem Cell how the Spred1 molecule is involved in hematopoietic stem cell self-renewal.

Recently, Spark Therapeutics (ONCE) reported that it had achieved positive results from its phase 1/2 study using SPK-9001 to treat patients with Hemophilia B. The most notable item from this form of treatment was able to reduce routine infusions of Factor IX concentrates.

Since it burst onto the scene a decade ago, CRISPR-Cas9 has shaken the field of genetics to its core. Offering a new genomic editing tool that’s faster, cheaper and more accurate than previous approaches, it opens up an astonishing breadth of possible applications.

Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism.